Because mammalian target of rapamycin (mTOR) is downstream effector of Akt, we utilized rapamycin, a mTOR inhibitor, and found rapamycin also suppressed PGE2-stimulated sphere formation in hepatoma cells (Fig. 6E). This evidence concerns the gene AKT1 and hepatocellular carcinoma.